IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025
1. IceCure projects $525,000 in sales for Q2 2025. 2. U.S. market unaffected by delays due to inventory levels. 3. $1.25 million total sales reported for H1 2025, down from $1.65 million. 4. Delayed shipments will boost Q3 results with $200,000 booked later. 5. Financial results will be detailed in August 2025.